Saumbon, Arabella .
HRN: 27-13-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
56mg
OD
T/c CNS Fungal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes